Skip to Main Content

Structural, functional & molecular neuroimaging biomarkers for AD

By Cortechs.ai

2 mins

Neuroimaging biomarkers are now routinely incorporated into AD clinical trials and are increasingly used in clinical practice. This paper broadly describes the development and use of these biomarkers as they relate to AD.

Download

Share

Topic
Published research

Insights

2 mins

Apr 26 2024

Cortechs.ai Announces Major FDA 510(k)-Pending Update to NeuroQuant Software

Read more about Cortechs.ai Announces Major FDA 510(k)-Pending Update to NeuroQuant Software

Cortechs.ai news

3 mins

Apr 3 2024

Cortechs.ai Appoints Kyle Frye as New Chief Executive Officer

Read more about Cortechs.ai Appoints Kyle Frye as New Chief Executive Officer

Cortechs.ai news

2 mins

Nov 21 2023

Our Normative Database

Whitepaper: How Cortechs.ai's normative database was created to accurately compare an individual’s brain structure volume to a healthy population.

Whitepapers

View our insights